Hyperlactatemia Clinical Trial
Official title:
Effect of Metformin on Lactate Metabolism in Healthy Subjects
The main objective of this study is to evaluate the influence of metformin on lactate
metabolism.
The main outcome is the lactate production following an exogenous lactate overload in
healthy male subjects without metformin and one week later with metformin.
Study design: Physiological study, controlled, open, non randomised
Healthy male subjects, 18 to 30 years old
Principal objective : To evaluate the influence of metformin on lactate metabolism
(production) following exogenous lactate overload.
- Objective 2: To evaluate the influence of metformin on lactate metabolism (production)
after muscular exercise.
- Objective 3: To evaluate the influence of metformin on lactate metabolism (elimination)
after exogenous lactate overload.
- Objective 4: To evaluate the influence of metformin on lactate metabolism (elimination)
after muscular exercise.
Principal outcome : Lactate production following exogenous lactate overload.
- Outcome 2: Production of lactate following muscular exercise test.
- Outcome 3 and 3': Parameters modelizing elimination of lactate following exogenous
lactate overload (bi-exponential model).
- Outcome 4 and 4': Parameters modelizing elimination of lactate following muscular
exercise test (bi-exponential model).
Inclusion criteria:
- Healthy male subjects, 18 to 30 years
- Body mass index (BMI) between 21 and 25 kg/m2 inclusive
- Informed consent
Exclusion criteria :
- Ward of court or under guardianship (sheltered adults)
- Adult unable to express their consent
- Person deprived of freedom by judicial or administrative decision
- Person hospitalised without their consent
- Person under legal protection
- Existence of a previously diagnosed pathology
- Existence of a metabolic condition (obesity, diabetes) or a family history of such
- Ongoing medical treatment.
;
Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05505396 -
Hyperglycaemia and Hyperlactataemia in Patients With Severe Acute Brain Injury
|
||
Completed |
NCT05032521 -
Treatment of Hyperlactatemia in Acute Circulatory Failure Based on Analysis of CO2: a Prospective Randomized Superiority Study (The LACTEL Study)
|
Phase 4 | |
Completed |
NCT05145049 -
The Relationship of Anesthesia Method With Serum Lactate Level in Craniotomies
|
||
Completed |
NCT03025659 -
Lactate Acidosis in Postoperative Hearts
|
||
Not yet recruiting |
NCT04315623 -
RCA for CRRT in Hyperlactatemia Patient With Increased Bleeding Risk
|
N/A | |
Completed |
NCT04710875 -
The Role of Lactate in Lipolysis and Catabolism in Humans
|
N/A | |
Completed |
NCT03078712 -
Early Goal Directed Therapy Using a Physiological Holistic View. The ANDROMEDA-SHOCK Study
|
N/A | |
Recruiting |
NCT03762005 -
Peripheral Perfusion Versus Lactate Targeted Fluid Resuscitation in Septic Shock
|
N/A | |
Completed |
NCT04410315 -
Hyperlactatemia During and After Tumorcraniotomy
|
||
Completed |
NCT02950753 -
Does Intravenous Lactated Ringer Solution Raise Measured Serum Lactate?
|
Early Phase 1 | |
Recruiting |
NCT03649009 -
Thiamine As An Adjuvant Therapy For Hyperlactatemia In Septic Shock Patients
|
N/A | |
Recruiting |
NCT04388267 -
Fluid REsponsiveness and Arterial ELASTANCE in Patients With Septic Shock or After Aortic Surgery
|
||
Not yet recruiting |
NCT06222021 -
Hyperlactacidemia in Major Abdominal Surgery and Monocarboxylate Receptors
|
N/A | |
Not yet recruiting |
NCT04284722 -
Perioperative Continuation of Metformin Therapy in Patients With Typ 2 Diabetes Mellitus Undergoing Non-cardiac Surgery
|
Phase 4 | |
Completed |
NCT00270673 -
Early Lactate-Directed Therapy in the Intensive Care Unit (ICU)
|
Phase 3 | |
Not yet recruiting |
NCT05953142 -
Use of Dobutamine in Patients With Sepsis and Maintained Hypoperfusion After Initial Volemic Resuscitation.
|
Phase 2 | |
Not yet recruiting |
NCT04046861 -
Influence of High Vitamin C Dose on Lactate During and After Extracorporeal Circulation
|
N/A | |
Completed |
NCT05649358 -
Pilot Testing a Novel Non-invasive Lactate Sensor
|
N/A | |
Completed |
NCT00471614 -
Effects of Uridine Supplementation on Metabolic Side Effects of Stavudine and Zidovudine
|
Phase 2 | |
Completed |
NCT04299815 -
Lactate in the Gut
|
N/A |